【発明の名称】複数の腫瘍において過剰発現される抗原CASB414 - GlaxoSmithKline Biologicals Society Anonymous

Title:

【発明の名称】複数の腫瘍において過剰発現される抗原CASB414

Document Type and Number:

Japanese Patent JP2003526320

Kind Code:

A

Abstract:

CASB414 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB414 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly colon cancers, autoimmune diseases, and related conditions.

More Like This:

WO/2001/055298	USE OF A NUCLEOTIDE SEQUENCE FOR ENHANCING PROTEIN SYNTHESIS AND EXPRESSION OF PROTEINS
JP2013048626	RECOMBINANT ADENOVIRUS ENCODING SPECIFIC IODINE TRANSPORTER (NIS)
JP5416934	Microorganisms into which the Mycinose biosynthetic gene has been introduced

Inventors:

Brooke, claudin, elvia, marie
Cassert, Jean-Pol
Coche, Thierry
Vinals-Basols, Carlota

Application Number:

JP2000537994A

Publication Date:

September 09, 2003

Filing Date:

March 17, 1999

Export Citation:

Click for automatic bibliography generation Help

Assignee:

GlaxoSmithKline Biologicals Society Anonymous

International Classes:

C12N15/09; A61K31/711; A61K38/00; A61K39/39; A61P35/00; A61P37/04; C07K14/47; C07K16/18; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/12; C12Q1/68; A61K39/00; (IPC1-7): C12N15/09; A61K31/711; A61K38/00; A61K39/39; A61P35/00; A61P37/04; C07K14/47; C07K16/18; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12Q1/68

Attorney, Agent or Firm:

Yusuke Hiraki (2 outside)

Previous Patent: リパーゼ変異体

Next Patent: 合成ベータ細胞による糖尿病の治療